Global Pharmaceuticals & Biotech Undervalued over 20% based on DCF

RemeGen

Market Cap: HK$78.9b

A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.

WuXi XDC Cayman

Market Cap: HK$77.8b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

Bruker

Market Cap: US$9.4b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.

Alkermes

Market Cap: US$9.1b

A biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

Shanghai Allist Pharmaceuticals

Market Cap: CN¥58.9b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.

Kyowa Kirin

Market Cap: JP¥1.4t

Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.

Shanghai Fosun Pharmaceutical (Group)

Market Cap: CN¥56.6b

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Qiagen

Market Cap: US$8.3b

Provides sample to insight solutions that transform biological samples into molecular insights worldwide.

ALK-Abelló

Market Cap: DKK 54.1b

An allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.

Pharmaron Beijing

Market Cap: CN¥49.6b

Operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally.

Bachem Holding

Market Cap: CHF 5.8b

Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.

Gedeon Richter

Market Cap: Ft2.2t

Researches, develops, manufactures, markets, and sells pharmaceutical products.

Avantor

Market Cap: US$7.0b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Ono Pharmaceutical

Market Cap: JP¥1.1t

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Ligand Pharmaceuticals

Market Cap: US$6.3b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

Grifols

Market Cap: €5.5b

Engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally.

3SBio

Market Cap: HK$48.9b

An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.

Twist Bioscience

Market Cap: US$6.2b

Manufactures and sells synthetic DNA-based products.

Apotex Health

Market Cap: CA$7.8b

Operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India.

Travere Therapeutics

Market Cap: US$5.3b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Stevanato Group

Market Cap: US$5.2b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Sotera Health

Market Cap: US$5.1b

Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

Caliway Biopharmaceuticals

Market Cap: NT$155.2b

Engages in the development of drugs for aesthetic medicine and chronic inflammation.

Aspen Pharmacare Holdings

Market Cap: R70.0b

Manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia.

Imeik Technology DevelopmentLtd

Market Cap: CN¥27.6b

Engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China.

Telix Pharmaceuticals

Market Cap: AU$5.7b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

Hanmi Pharm

Market Cap: ₩5.9t

A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.

Livzon Pharmaceutical Group

Market Cap: CN¥24.5b

Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.

MGI Tech

Market Cap: CN¥24.3b

Engages in the research, development, production, and sale of DNA sequencing instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries in China and internationally.

Laboratorios Farmaceuticos Rovi

Market Cap: €2.9b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Chengdu Kanghong Pharmaceutical Group

Market Cap: CN¥20.6b

Engages in the research, development, manufacture, and sale of pharmaceuticals and medical devices in China.

SCHOTT Pharma KGaA

Market Cap: €2.6b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.

Hypera

Market Cap: R$14.8b

Operates as a pharmaceutical company in Brazil.

Tecan Group

Market Cap: CHF 2.2b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

Curaleaf Holdings

Market Cap: CA$3.9b

Engages in the retail and wholesale of cannabis products in the United States and internationally.

Dermapharm Holding

Market Cap: €2.4b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.